Ulcerative colitis-associated colorectal cancer.

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
• Colorectal cancer (CRC) is a serious complication of long-standing UC, termed UC-CRC.
• UC-CRC patients often present with younger age, multiple lesions, and specific histological subtypes.

Purpose of the Study:

• To review the association between ulcerative colitis and colorectal cancer.
• To identify risk factors and the progression pathway of UC-CRC.
• To discuss surveillance strategies and potential chemopreventive agents for UC-CRC.

Main Methods:

• Literature review of studies on UC and CRC.
• Analysis of epidemiological data and clinical characteristics of UC-CRC.
• Examination of the histological progression from dysplasia to adenocarcinoma in UC patients.

Main Results:

• CRC risk increases 8-10 years post-UC diagnosis.
• Key risk factors include disease duration, extent, inflammation, family history, and primary sclerosing cholangitis.
• The progression involves stages from non-dysplastic mucosa to invasive adenocarcinoma.

Conclusions:

• Colonoscopy surveillance is crucial for reducing UC-CRC risk and mortality.
• Genetic alterations are implicated in UC-CRC development.
• 5-aminosalicylates show potential as a chemopreventive therapy for CRC in UC patients.